Elizabeth J. Scharman, PharmD, DABAT, BCPS, FAACT

Adjunct Associate Professor of Medicine

Director

Organization:

West Virginia University Charleston Campus

Department:

West Virginia Poison Center

Classification:

Admin

Professor

Organization:

West Virginia University Charleston Campus

Department:

School of Pharmacy

Classification:

Faculty

• BS, Butler University, 1986
• PharmD, Virginia Commonwealth University (Medical College of Virginia), 1991

Thomasson ED, Scharman E, Fechter-Leggett E, et al. Acute health effects after the Elk River chemical spill, West Virginia, January 2014. Public Health Rep 2017;132:196-202.

McKay C, Scharman EJ. Intentional and Inadvertent Chemical Contamination of Food, Water, and Medication. Emerg Med Clin North Am. 2015 Feb;33(1):153-177. doi: 10.1016/j.emc.2014.09.011. Epub 2014 Nov 15.

Scharman EJ, Troutman WG. Prevention of kidney injury following rhabdomyolysis: a systematic review of the literature. Ann Pharmacother 2013;47:90-105.

Scharman EJ. Commentary: Liquid “Laundry Pods”: A Missed Global Toxicosurveillance Opportunity. Clin Toxicol (Phila) 2012: DOI: 10.3109/15563650.2012.713109

Scharman EJ, Erdman AR, Cobaugh DJ, Olson KR, Woolf AD, Caravati EM, Chyka PA, Booze LL, Manoguerra AS, Nelson LL, Christianson G, Troutman WG.  Methylphenidate poisoning: an evidence-based consensus guideline for out-of-hospital management.  Clin Toxicol (Phila) 2007;45:737-752. 

Scharman EJ, Erdman AR, Wax PM, Chyka PA, Caravati EM, Nelson LS, Manoguerra AS, Christianson G, Olson KR, Woolf AD, Keyes DC, Booze LL, Troutman WG.  Diphenhydramine and Diminhydrinate Poisoning: An Evidence-Based Consensus Guideline for Out-of-Hospital Management.  Clin Toxicol (Phila) 2006;44:205-223.

Scharman EJ, Noffsinger VD.  Copperhead snakebites: clinical severity of local effects.  Ann Emerg Med 2001;38:55-61.

Scharman EJ, Hutzler JM, Rosencrance JG, Tracy TS.  Single dose pharmacokinetics of syrup of ipecac.  Ther Drug Monit 2000; 22:566-573. (funded)

Elizabeth J. Scharman, Pharm.D., DABAT, BCPS, FAACT has been the Director of the West Virginia Poison Center (WVPC) and a full-time faculty member with the West Virginia University (WVU) School of Pharmacy since July 1992.  Dr. Scharman works out of the WVU Robert C. Byrd Health Sciences Center Charleston Division.  She received tenure in 1998 and became a full Professor within the Department of Clinical Pharmacy in July 2003.  Dr. Scharman received a B.S. in Pharmacy (1986) from Butler University and a Pharm.D. (1991) from Virginia Commonwealth University (Medical College of Virginia) then completed a Clinical Toxicology Fellowship (1992) at the Pittsburgh Poison Center affiliated with the University of Pittsburgh.  She became a Diplomate of the American Board of Applied Toxicology (ABAT) in 1992 and a Board Certified Pharmacotherapy Specialist in 1995.   Dr. Scharman has held numerous elected positions on boards of national organizations including the American Academy of Clinical Toxicology (AACT), the American Board of Applied Toxicology (in which she also served as President from 2004 to 2006), and the American Association of Poison Control Centers.  She currently serves as a member and/or Chair of multiple of national committees; many of which are working to advance the accuracy and rigor of toxicosurveillance databases.  In 2014, Dr. Scharman was appointed to the editorial board of the journal, Clinical Toxicology (Phila); she has been Chair of the Toxicology and Poison Control Editorial Panel for the journal, Annals of Pharmacotherapy, since 2003.  Dr. Scharman teaches the clinical toxicology, disaster planning, and substance abuse related classes for the WVU School of Pharmacy in addition to content area related to adverse drug reactions.  She also provides continuing education presentations for physicians, nurses, and pharmacists throughout WV on topics related to clinical toxicology and drugs of abuse.  Dr. Scharman has multiple peer reviewed publications in the field of clinical toxicology and evidence-based practice.